153 related articles for article (PubMed ID: 11216671)
1. Tumor amplified protein expression therapy: Salmonella as a tumor-selective protein delivery vector.
Zheng LM; Luo X; Feng M; Li Z; Le T; Ittensohn M; Trailsmith M; Bermudes D; Lin SL; King IC
Oncol Res; 2000; 12(3):127-35. PubMed ID: 11216671
[TBL] [Abstract][Full Text] [Related]
2. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
Cunningham C; Nemunaitis J
Hum Gene Ther; 2001 Aug; 12(12):1594-6. PubMed ID: 11529249
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the acute and subchronic toxic effects in mice, rats, and monkeys of the genetically engineered and Escherichia coli cytosine deaminase gene-incorporated Salmonella strain, TAPET-CD, being developed as an antitumor agent.
Lee KC; Zheng LM; Margitich D; Almassian B; King I
Int J Toxicol; 2001; 20(4):207-17. PubMed ID: 11563416
[TBL] [Abstract][Full Text] [Related]
4. Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent.
King I; Bermudes D; Lin S; Belcourt M; Pike J; Troy K; Le T; Ittensohn M; Mao J; Lang W; Runyan JD; Luo X; Li Z; Zheng LM
Hum Gene Ther; 2002 Jul; 13(10):1225-33. PubMed ID: 12133275
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of VNP20009, an attenuated Salmonella, in murine tumor models.
Luo X; Li Z; Lin S; Le T; Ittensohn M; Bermudes D; Runyab JD; Shen SY; Chen J; King IC; Zheng LM
Oncol Res; 2001; 12(11-12):501-8. PubMed ID: 11939414
[TBL] [Abstract][Full Text] [Related]
6. Optimization of tumor-targeted gene delivery by engineered attenuated Salmonella typhimurium.
Mei S; Theys J; Landuyt W; Anne J; Lambin P
Anticancer Res; 2002; 22(6A):3261-6. PubMed ID: 12530073
[TBL] [Abstract][Full Text] [Related]
7. Salmonella-based tumor-targeted cancer therapy: tumor amplified protein expression therapy (TAPET) for diagnostic imaging.
Tjuvajev J; Blasberg R; Luo X; Zheng LM; King I; Bermudes D
J Control Release; 2001 Jul; 74(1-3):313-5. PubMed ID: 11489512
[TBL] [Abstract][Full Text] [Related]
8. Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model.
Lee CH; Wu CL; Shiau AL
Cancer Gene Ther; 2005 Feb; 12(2):175-84. PubMed ID: 15375381
[TBL] [Abstract][Full Text] [Related]
9. Tumor-targeted Salmonella typhimurium overexpressing cytosine deaminase: a novel, tumor-selective therapy.
King I; Itterson M; Bermudes D
Methods Mol Biol; 2009; 542():649-59. PubMed ID: 19565926
[TBL] [Abstract][Full Text] [Related]
10. Oral delivery of tumor-targeting Salmonella exhibits promising therapeutic efficacy and low toxicity.
Chen G; Wei DP; Jia LJ; Tang B; Shu L; Zhang K; Xu Y; Gao J; Huang XF; Jiang WH; Hu QG; Huang Y; Wu Q; Sun ZH; Zhang JF; Hua ZC
Cancer Sci; 2009 Dec; 100(12):2437-43. PubMed ID: 19793349
[TBL] [Abstract][Full Text] [Related]
11. Regional delivery of an adenovirus vector containing the Escherichia coli cytosine deaminase gene to provide local activation of 5-fluorocytosine to suppress the growth of colon carcinoma metastatic to liver.
Ohwada A; Hirschowitz EA; Crystal RG
Hum Gene Ther; 1996 Aug; 7(13):1567-76. PubMed ID: 8864757
[TBL] [Abstract][Full Text] [Related]
12. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
Hanna NN; Mauceri HJ; Wayne JD; Hallahan DE; Kufe DW; Weichselbaum RR
Cancer Res; 1997 Oct; 57(19):4205-9. PubMed ID: 9331076
[TBL] [Abstract][Full Text] [Related]
13. Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice.
Gnant MF; Puhlmann M; Alexander HR; Bartlett DL
Cancer Res; 1999 Jul; 59(14):3396-403. PubMed ID: 10416601
[TBL] [Abstract][Full Text] [Related]
14. Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models.
Lee CH; Wu CL; Shiau AL
J Gene Med; 2004 Dec; 6(12):1382-93. PubMed ID: 15468191
[TBL] [Abstract][Full Text] [Related]
15. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor.
Mullen CA; Coale MM; Lowe R; Blaese RM
Cancer Res; 1994 Mar; 54(6):1503-6. PubMed ID: 8137255
[TBL] [Abstract][Full Text] [Related]
16. Oral cytokine gene therapy against murine tumor using attenuated Salmonella typhimurium.
Yuhua L; Kunyuan G; Hui C; Yongmei X; Chaoyang S; Xun T; Daming R
Int J Cancer; 2001 Nov; 94(3):438-43. PubMed ID: 11745427
[TBL] [Abstract][Full Text] [Related]
17. Tumor-targeted Salmonella as a novel anticancer vector.
Pawelek JM; Low KB; Bermudes D
Cancer Res; 1997 Oct; 57(20):4537-44. PubMed ID: 9377566
[TBL] [Abstract][Full Text] [Related]
18. Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect.
Pierrefite-Carle V; BaquƩ P; Gavelli A; Mala M; Chazal M; Gugenheim J; Bourgeon A; Milano G; Staccini P; Rossi B
J Natl Cancer Inst; 1999 Dec; 91(23):2014-9. PubMed ID: 10580026
[TBL] [Abstract][Full Text] [Related]
19. Regional delivery and selective expression of a high-activity yeast cytosine deaminase in an intrahepatic colon cancer model.
Zhang M; Li S; Nyati MK; DeRemer S; Parsels J; Rehemtulla A; Ensminger WD; Lawrence TS
Cancer Res; 2003 Feb; 63(3):658-63. PubMed ID: 12566311
[TBL] [Abstract][Full Text] [Related]
20. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine.
Hirschowitz EA; Ohwada A; Pascal WR; Russi TJ; Crystal RG
Hum Gene Ther; 1995 Aug; 6(8):1055-63. PubMed ID: 7578418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]